Form 8-K - Current report:
SEC Accession No. 0001104659-20-128459
Filing Date
2020-11-23
Accepted
2020-11-23 16:10:45
Documents
13
Period of Report
2020-11-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2036954d1_8k.htm   iXBRL 8-K 32328
  Complete submission text file 0001104659-20-128459.txt   252447

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA elan-20201117.xsd EX-101.SCH 3898
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE elan-20201117_def.xml EX-101.DEF 27027
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE elan-20201117_lab.xml EX-101.LAB 37941
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE elan-20201117_pre.xml EX-101.PRE 25639
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2036954d1_8k_htm.xml XML 5162
Mailing Address 2500 INNOVATION WAY GREENFIELD IN 46140
Business Address 2500 INNOVATION WAY GREENFIELD IN 46140 877-352-6261
Elanco Animal Health Inc (Filer) CIK: 0001739104 (see all company filings)

EIN.: 825497352 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38661 | Film No.: 201337335
SIC: 2834 Pharmaceutical Preparations